Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mengshang Xiong"'
Autor:
Yuanyuan Yang, Xiaolong Zhang, Fangzhen Lin, Mengshang Xiong, Dongmei Fan, Xiangfei Yuan, Yang Lu, Yuewen Song, Yizi Zhang, Mu Hao, Zhou Ye, Yanjun Zhang, Jianxiang Wang, Dongsheng Xiong
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-16 (2019)
Abstract Background PD-1/PD-L1 blockade can confer durable benefits in the treatment of metastatic cancers, but the response rate remains modest and potential adverse effects occur sometimes. Concentrating immunotherapeutic agents at the site of dise
Externí odkaz:
https://doaj.org/article/6956e04595b74fbaa18ecd84cae4320d
Autor:
Fangzhen Lin, Mengshang Xiong, Wei Hao, Yuewen Song, Ruoqi Liu, Yuanyuan Yang, Xiangfei Yuan, Dongmei Fan, Yizi Zhang, Mu Hao, Zhou Ye, Yang Lu, Yanjun Zhang, Jianxiang Wang, Dongsheng Xiong
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Macrophages as components of the innate immune system play a critical role in antitumor responses. Strategies for targeting CD47 are becoming a hot spot for cancer therapy. The expression of CD47 is exercised by macrophages to make a distinction betw
Externí odkaz:
https://doaj.org/article/7e8e2a0af6524110a2671d98a269babf
Autor:
Wei Hao, Mengshang Xiong, Yanjun Zhang, Fangzhen Lin, Xiangfei Yuan, Dong-Mei Fan, Yang Lu, Zhou Ye, Dong-sheng Xiong, Xiaomin Lei, Xiaolong Zhang, Yuanyuan Yang, Ruoqi Liu, Jianxiang Wang
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 45(2)
Multiple myeloma (MM) is a B-cell malignancy for which new treatments are urgently needed. Redirecting the activity of T cells by bispecific antibodies against tumor cells is a potent approach. The B-cell maturation antigen (BCMA) is a highly plasma
Autor:
Yanjun Zhang, Mengshang Xiong, Dongsheng Xiong, Xiangfei Yuan, Jianxiang Wang, Yuewen Song, Mu Hao, Yang Lu, Wei Hao, Zhou Ye, Ruoqi Liu, Yuanyuan Yang, Fangzhen Lin, Dongmei Fan, Yizi Zhang
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology
Frontiers in Oncology
Macrophages as components of the innate immune system play a critical role in antitumor responses. Strategies for targeting CD47 are becoming a hot spot for cancer therapy. The expression of CD47 is exercised by macrophages to make a distinction betw
Autor:
Zhou Ye, Yuewen Song, Yizi Zhang, Mengshang Xiong, Jianxiang Wang, Mu Hao, Xiangfei Yuan, Yuanyuan Yang, Xiaolong Zhang, Dongmei Fan, Yang Lu, Dongsheng Xiong, Yanjun Zhang, Fangzhen Lin
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-16 (2019)
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-16 (2019)
Background PD-1/PD-L1 blockade can confer durable benefits in the treatment of metastatic cancers, but the response rate remains modest and potential adverse effects occur sometimes. Concentrating immunotherapeutic agents at the site of disease was b
Autor:
Yuanyuan Yang, Xiaolong Zhang, Fangzhen Lin, Mengshang Xiong, Dongmei Fan, Xiangfei Yuan, Lu, Yang, Yuewen Song, Yizi Zhang, Hao, Mu, Ye, Zhou, Yanjun Zhang, Jianxiang Wang, Dongsheng Xiong
Figure S1. Schematic representation of the therapeutic strategy. Figure S2. Schematic representation of lentiviral expression vector for E1A. Figure S3. Western blot analysis of CD3-HAC. Figure S4. Transduced MDA-MB-231 cells secreted CD3-HAC constan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dbe1d6f9e8d643967751639919f5b3f